Publications

Tyshchenko I, Lévy S, Jin J, Tahayori B, Blunck Y, Johnston LA. What can we gain from subpopulation universal pulses? A simulation-based study. Magn Reson Med. 2024 Feb;91(2):570-582. Link to Publication

Phua CS, Moffat B, Paul E, Ang M, Law M, Bertram K, Hutton E. Quantitative analysis of MR T2 relaxation times in neck muscles. Magn Reson Imaging. 2023 Nov;103:156-161. Link to Publication

Ganesan S, A Moffat B, Van Dam NT, Lorenzetti V, Zalesky A. Meditation attenuates default-mode activity: A pilot study using ultra-high field 7 Tesla MRI. Brain Res Bull. 2023 Oct 15;203:110766.  Link to Publication   

Crawford LS, Mills EP, Peek A, Macefield VG, Keay KA, Henderson LA. Function and biochemistry of the dorsolateral prefrontal cortex during placebo analgesia: how the certainty of prior experiences shapes endogenous pain relief. Cereb Cortex. 2023 Aug 23;33(17):9822-9834.         Link to Publication

Ravanfar P, Syeda WT, Rushmore RJ, Moffat B, Lyall AE, Merritt AH, Devenyi GA, Chakravarty MM, Desmond P, Cropley VL, Makris N, Shenton ME, Bush AI, Velakoulis D, Pantelis C, Walterfang M. Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study. AJNR Am J Neuroradiol. 2023 Jul;44(7):768-775.  Link to Publication

Chi D, Blunck Y, Glarin R, Davey CE, Zhang X, Stäb D, Pfeuffer J, Johnston LA, Jin J. Hybrid adiabatic pulse with asymmetry (HAPY): An asymmetric adiabatic pulse with an application in pulsed arterial spin labeling at 7T. Magn Reson Med. 2023 Jul;90(1):177-193. Link to Publication

Agathos J, Steward T, Davey CG, Felmingham KL, Ince S, Moffat BA, Glarin RK, Harrison BJ. Differential engagement of the posterior cingulate cortex during cognitive restructuring of negative self- and social beliefs. Soc Cogn Affect Neurosci. 2023 May 13;18(1):nsad024.               Link to Publication

Broatch JR, Zarekookandeh N, Glarin R, Strik M, Johnston LA, Moffat BA, Bird LJ, Gunningham K, Churilov L, Johns HT, Askew CD, Levinger I, O'Riordan SF, Bishop DJ, Brodtmann A. Train Smart Study: protocol for a randomised trial investigating the role of exercise training dose on markers of brain health in sedentary middle-aged adults. BMJ Open. 2023 May 24;13(5):e069413            Link to Publication

Crawford LS, Meylakh N, Macey PM, Macefield VG, Keay KA, Henderson LA. Stimulus-independent and stimulus-dependent neural networks underpin placebo analgesia responsiveness in humans. Commun Biol. 2023 May 27;6(1):569.  Link to Publication

Ince S, Steward T, Harrison BJ, Jamieson AJ, Davey CG, Agathos JA, Moffat BA, Glarin RK, Felmingham KL. Subcortical contributions to salience network functioning during negative emotional processing. Neuroimage. 2023 Apr 15;270:119964.  Link to Publication

Strik M, Clough M, Solly EJ, Glarin R, White OB, Kolbe SC, Fielding J. Brain network dynamics in people with visual snow syndrome. Hum Brain Mapp. 2023 Apr 1;44(5):1868-1875                         Link to Publication

Crawford L, Mills E, Meylakh N, Macey PM, Macefield VG, Henderson LA. Brain activity changes associated with pain perception variability. Cereb Cortex. 2023 Mar 21;33(7):4145-4155.              Link to Publication

Tinoco Mendoza FA, Hughes TES, Robertson RV, Crawford LS, Meylakh N, Macey PM, Macefield VG, Keay KA, Henderson LA. Detailed organisation of the human midbrain periaqueductal grey revealed using ultra-high field magnetic resonance imaging. Neuroimage. 2023 Feb 1;266:119828.   Link to Publication

Strik M, Eijlers AJ, Dekker I, Broeders TA, Douw L, Killestein J, Kolbe SC, Geurts JJ, Schoonheim MM. Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis. Mult Scler. 2023 Jan;29(1):81-91. Link to Publication

Ganesan S, Beyer E, Moffat B, Van Dam NT, Lorenzetti V, Zalesky A. Focused attention meditation in healthy adults: A systematic review and meta-analysis of cross-sectional functional MRI studies. Neurosci Biobehav Rev. 2022 Oct;141:104846.   Link to Publication

Cofré Lizama LE, Strik M, Van der Walt A, Kilpatrick TJ, Kolbe SC, Galea MP. Gait stability reflects motor tracts damage at early stages of multiple sclerosis. Mult Scler. 2022 Oct;28(11):1773-1782.   Link to Publication

Ravanfar P, Syeda WT, Jayaram M, Rushmore RJ, Moffat B, Lin AP, Lyall AE, Merritt AH, Yaghmaie N, et al. In Vivo 7-Tesla MRI Investigation of Brain Iron and Its Metabolic Correlates in Chronic Schizophrenia. Schizophrenia (Heidelb). 2022 Oct 26;8(1):86.   Link to Publication

McCarthy L, Verma G, Hangel G, Neal A, Moffat BA, Stockmann JP, Andronesi OC, Balchandani P, Hadjipanayis CG. Application of 7T MRS to High-Grade Gliomas. AJNR Am J Neuroradiol. 2022 Oct;43(10):1378-1395.     Link to Publication

Robertson RV, Crawford LS, Meylakh N, Macey PM, Macefield VG, Keay KA, Henderson LA. Regional hypothalamic, amygdala, and midbrain periaqueductal gray matter recruitment during acute pain in awake humans: A 7-Tesla functional magnetic resonance imaging study. Neuroimage. 2022 Oct 1;259:119408. Link to Publication

Harrison BJ, Davey CG, Savage HS, Jamieson AJ, Leonards CA, Moffat BA, Glarin RK, Steward T. Dynamic subcortical modulators of human default mode network function. Cereb Cortex. 2022 Sep 19;32(19):4345-4355.  Link to Publication

Wu C, Blunck Y, Johnston LA. The "Spin-3/2 Bloch Equation": System matrix formalism of excitation, relaxation, and off-resonance effects in biological tissue. Magn Reson Med. 2022 May 24.  Link to Publication

Syeda W, Ermine CM, Khilf MS, Wright D, Brait VH, Nithianantharajah J, Kolbe S, Johnston LA, Thompson LH, Brodtmann A. Long-term structural brain changes in adult rats after mild ischaemic stroke. Brain Commun. 2022 Jul 22;4(4):fcac185. Link to Publication

Ordidge R, Blunck Y, Glarin R, Moffat B, Johnston L. Ultrahigh field brain magnetic resonance imaging using semiadiabatic radiofrequency pulses. NMR Biomed. 2022 Jun;35(6): e4672.          Link to Publication

Laing PAF, Steward T, Davey CG, Felmingham KL, Fullana MA, Vervliet B, Greaves MD, Moffat B, Glarin RK, Harrison BJ. Cortico-Striatal Activity Characterizes Human Safety Learning via Pavlovian Conditioned Inhibition. J Neurosci. 2022 Jun 22;42(25):5047-5057.Link to Publication

Strik M, Clough M, Solly EJ, Glarin R, White OB, Kolbe SC, Fielding J. Microstructure in patients with visual snow syndrome: an ultra-high field morphological and quantitative MRI study. Brain Commun. 2022 Jun 23;4(4):fcac164.   Link to Publication

Syeda WT, Wannan CMJ, Merritt AH, Raghava JM, Jayaram M, Velakoulis D, Kristensen TD, Soldatos RF, Tonissen S, Thomas N, Ambrosen KS, Sørensen ME, Fagerlund B, Rostrup E, Glenthøj BY, Skafidas E, Bousman CA, Johnston LA, Everall I, Ebdrup BH, Pantelis C. Cortico-cognition coupling in treatment resistant schizophrenia. Neuroimage Clin. 2022;35:103064.  Link to Publication

Chan YM, Glarin R, Moffat BA, Bode S, McKendrick AM. Relating the cortical visual contrast gain response to spectroscopy-measured excitatory and inhibitory metabolites in people who experience migraine. PLoS One. 2022 Apr 7;17(4):e0266130. Link to Publication

Boonstra FM, Clough M, Strik M, van der Walt A, Butzkueven H, White OB, Law M, Fielding J, Kolbe SC. Longitudinal tracking of axonal loss using diffusion magnetic resonance imaging in multiple sclerosis. Brain Commun. 2022 Mar 17;4(2):fcac065.  Link to Publication

Steward T, Kung PH, Davey CG, Moffat BA, Glarin RK, Jamieson AJ, Felmingham KL, Harrison BJ. A thalamo-centric neural signature for restructuring negative self-beliefs. Mol Psychiatry. 2022 Mar;27(3):1611-1617. Link to Publication

Zamani A, O'Brien TJ, Kershaw J, Johnston LA, Semple BD, Wright DK. White matter changes following experimental pediatric traumatic brain injury: an advanced diffusion-weighted imaging investigation. Brain Imaging Behav. 2021 Dec;15(6):2766-2774.  Link to Publication

Crawford LS, Mills EP, Hanson T, Macey PM, Glarin R, Macefield VG, Keay KA, Henderson LA. Brainstem Mechanisms of Pain Modulation: A within-Subjects 7T fMRI Study of Placebo Analgesic and Nocebo Hyperalgesic Responses. J Neurosci. 2021 Nov 24;41(47):9794-9806. Link to Publication  

Savage HS, Davey CG, Wager TD, Garfinkel SN, Moffat BA, Glarin RK, Harrison BJ. Neural mediators of subjective and autonomic responding during threat learning and regulation. Neuroimage. 2021 Oct 24;245:118643.   Link to Publication 

Strik M, Chard DT, Dekker I, Meijer KA, Eijlers AJ, Pardini M, Uitdehaag BM, Kolbe SC, Geurts JJ, Schoonheim MM. Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis. Mult Scler. 2021 Aug;27(9):1364-1373.   Link to Publication

Strik M, Shanahan CJ, van der Walt A, Boonstra FMC, Glarin R, Galea MP, Kilpatrick TJ, Geurts JJG, Cleary JO, Schoonheim MM, Kolbe SC. Functional correlates of motor control impairments in multiple sclerosis: A 7 Tesla task functional MRI study. Hum Brain Mapp. 2021 Jun 1;42(8):2569-2582.  Link to Publication

Nicolo JP, Moffat B, Wright DK, Sinclair B, Neal A, Lui E, Desmond P, Glarin R, Davis KA, Reddy R, Yan B, O'Brien TJ, Kwan P. 7T Magnetic Resonance Imaging Quantification of Brain Glutamate in Acute Ischaemic Stroke. J Stroke. 2021 May;23(2):281-284. doi: 10.5853/jos.2020.04784. Epub 2021 May 31. Link to Publication

Nicolo JP, Chen Z, Moffat B, Wright DK, Sinclair B, Glarin R, Neal A, Thijs V, Seneviratne U, Yan B, Cloud G, O'Brien TJ, Kwan P. Study protocol for a phase II randomised, double-blind, placebo-controlled trial of perampanel as an antiepileptogenic treatment following acute stroke. BMJ Open. 2021 May 10;11(5):e043488. Link to Publication

Brait VH, Wright DK, Nategh M, Oman A, Syeda WT, Ermine CM, O'Brien KR, Werden E, Churilov L, Johnston LA, Thompson LH, Nithianantharajah J, Jackman KA, Brodtmann A. Longitudinal hippocampal volumetric changes in mice following brain infarction. Sci Rep. 2021 May 13;11(1):10269.  Link to Publication

Yaghmaie N, Syeda WT, Wu C, Zhang Y, Zhang TD, Burrows EL, Brodtmann A, Moffat BA, Wright DK, Glarin R, Kolbe S, Johnston LA. QSMART: Quantitative susceptibility mapping artifact reduction technique. Neuroimage. 2021 May 1; 231:117701.  Link to Publication

Shishegar R, Pizzagalli F, Georgiou-Karistianis N, Egan GF, Jahanshad N, Johnston LA. A gyrification analysis approach based on Laplace Beltrami eigenfunction level sets. Neuroimage. 2021 Apr 1;229:117751.  Link to Publication

Bullock M, Jackson GD. and Abbott DF. Artifact Reduction in Simultaneous EEG-fMRI: A Systematic Review of Methods and Contemporary Usage. Frontiers in Neurology.  2021 Mar; 12:193.  Link to Publication

Gao Y, Zhu X, Moffat BA, Glarin R, Wilman AH, Pike GB, Crozier S, Liu F, Sun H. xQSM: quantitative susceptibility mapping with octave convolutional and noise-regularized neural networks. NMR Biomed. 2021 Mar;34(3):e4461.  Link to Publication

Strik M, Cofré Lizama LE, Shanahan CJ, van der Walt A, Boonstra FMC, Glarin R, Kilpatrick TJ, Geurts JJG, Cleary JO, Schoonheim MM, Galea MP, Kolbe SC.  Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patients  Brain Communications, 2021 Mar; fcab032.   Link to Publication

Glarin RK, Nguyen BN, Cleary JO, Kolbe SC, Ordidge RJ, Bui BV, McKendrick AM, Moffat BA. MR-EYE: High-Resolution MRI of the Human Eye and Orbit at Ultrahigh Field (7T). Magn Reson Imaging Clin N Am. 2021 Feb;29(1):103-116.  Link to Publication

Ravanfar P, Loi SM, Syeda WT, Van Rheenen TE, Bush AI, Desmond P, Cropley VL, Lane DJR, Opazo CM, Moffat BA, Velakoulis D, Pantelis C. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Front Neurosci. 2021 Feb 18;15:618435.    Link to Publication

Davey CE, Grayden DB, Johnston LA. Correcting for non-stationarity in BOLD-fMRI connectivity analyses. Frontiers in Neurosci., 2021 Feb; 15: 574979                  Link to Publication

Nguyen BN, Cleary JO, Glarin R, Kolbe SC, Moffat BA, Ordidge RJ, Bui BV, McKendrick AM. Ultra-High Field Magnetic Resonance Imaging of the Retrobulbar Optic Nerve, Subarachnoid Space, and Optic Nerve Sheath in Emmetropic and Myopic Eyes. Transl Vis Sci Technol. 2021 Feb 5;10(2):8.  Link to Publication

Ordidge R, Cleary J, Glarin R, Blunck Y, Farquharson S, Moffat B. Ultra-high-field MRI using composite RF (STEP) pulses. NMR Biomed. 2021 Feb;34(2):e4445.  Link to Publication

Gonen OM, Moffat BA, Kwan P, O'Brien TJ, Desmond PM, Lui E. Resting-state functional connectivity and quantitation of glutamate and GABA of the PCC/precuneus by magnetic resonance spectroscopy at 7T in healthy individuals. PLoS One. 2020 Dec 29;15(12):e0244491. Link to Publication

Gonen OM, Moffat BA, Desmond PM, Lui E, Kwan P, O'Brien TJ. Seven-tesla quantitative magnetic resonance spectroscopy of glutamate, γ-aminobutyric acid, and glutathione in the posterior cingulate cortex/precuneus in patients with epilepsy. Epilepsia. 2020 Dec;61(12):2785-2794.     Link to Publication

Marzbanrad F, Yaghmaie N, Jelinek HF. A framework to quantify controlled directed interactions in network physiology applied to cognitive function assessment. Sci Rep. 2020 Oct 28;10(1):18505.  Link to Publication

Gonen OM, Moffat BA, Kwan P, O'Brien TJ, Desmond PM, Lui E. Reproducibility of Glutamate, Glutathione, and GABA Measurements in vivo by Single-Voxel STEAM Magnetic Resonance Spectroscopy at 7-Tesla in Healthy Individuals. Front Neurosci. 2020 Sep 15;14:566643.               Link to Publication

Kottaram A, Johnston LA, Tian Y, Ganella EP, Laskaris L, Cocchi L, McGorry P, Pantelis C, Kotagiri R, Cropley V, Zalesky A. Predicting individual improvement in schizophrenia symptom severity at 1-year follow-up: Comparison of connectomic, structural, and clinical predictors. Hum Brain Mapp. 2020 Aug;41(12):3342-57.  Link to Publication

Strik M, Shanahan CJ,  Van der Walt A, Boonstra FMC,  Glarin R, Galea MP, Kilpatrick TJ, Geurts JJG, Cleary JO, Schoonheim MM, Kolbe SC.  Functional activation changes at ultra-high field related to upper and lower limb impairments in multiple sclerosis. MedRxiv, 2020 Aug 15.         Link to Publication

Yoo PE, Oxley TJ, Hagan MA, John S, Ronayne SM, Rind GS, Brinded AM, Opie NL, Moffat BA, Wong YT. Distinct Neural Correlates Underlie Inhibitory Mechanisms of Motor Inhibition and Motor Imagery Restraint. Front Behav Neurosci. 2020 Jun;14:77.  Link to Publication

Kolbe SC, Syeda W, Blunck Y, Glarin R, Law M, Johnston LA, Cleary JO. Microstructural correlates of ²³Na relaxation in human brain at 7 Tesla. Neuroimage. 2020 May; 211:116609.                           Link to Publication

Boonstra FMC, Evans A, Noffs G, Perera T, Jokubaitis V, Stankovich J, Vogel AP, Moffat BA, Butzkueven H, Kolbe SC, van der Walt A OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas. Mult Scler Relat Disord. 2020 May; 40:101984. doi: 10.1016/j.msard.2020.101984.  Link to Publication

Boonstra FM, Noffs G, Perera T, Jokubaitis VG, Vogel AP, Moffat BA, Butzkueven H, Evans A, van der Walt A, Kolbe SC. Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis. Mult Scler. 2020 May;26(6):696-705.     Link to Publication

Sun H, Cleary JO, Glarin R, Kolbe SC, Ordidge RJ, Moffat BA, Pike GB.Extracting more for less: multi-echo MP2RAGE for simultaneous T1 -weighted imaging, T1 mapping, R 2 * mapping, SWI, and QSM from a single acquisition. Magn Reson Med. 2020 Apr;83(4):1178-91.                                 Link to Publication

Blunck Y, Kolbe SC, Moffat BA, Ordidge RJ, Cleary JO, Johnston LA. Compressed sensing effects on quantitative analysis of undersampled human brain sodium MRI. Magn Reson Med. 2020; Mar; 83(3):1025-33.  Link to Publication

Ravanfar P, Loi S, Van Rheenen T, Bush A, Desmond P, Cropley V, Moffat B, Velakoulis D, Pantelis C.  Systematic review protocol: Quantitative susceptibility mapping of brain iron accumulation in neurodegenerative diseases.  MedRxiv, 2020 Feb 15.  Link to Publication

2019

Rana S, Shishegar R, Quezada S, Johnston L, Walker DW, Tolcos M. The subplate: a potential driver of cortical folding? Cereb Cortex. 2019 Dec; 29(11): 4697 -4708.  Link to Publication

Green EM, Blunck Y, Tahayori B, Farrell PM, Korte JC, Johnston LA. Spin Lock Adiabatic Correction (SLAC) for B1-insensitive pulse design at 7T. J Magn Reson. 2019 Nov; 308: 106565.                       Link to Publication

Wright DK, Brady RD, Kamnaksh A, Trezise J, Sun M, McDonald SJ, Mychasiuk R, Kolbe SC, Law M, Johnston LA, O'Brien TJ, Agoston DV, Shultz SR. Repeated mild traumatic brain injuries induce persistent changes in plasma protein and magnetic resonance imaging biomarkers in the rat. SciRep 2019 Oct; 9(1) :4626.  Link to Publication

Gajamange S, Shelton A, Clough M, White O, Fielding J, Kolbe S. Functional correlates of cognitive dysfunction in clinically isolated syndromes. PLoS One. 2019 Jul 17;14(7):e0219590.                   Link to Publication

Gajamange S, Stankovich J, Egan G, Kilpatrick T, Butzkueven H, Fielding J, van der Walt A, Kolbe S. Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis. Mult Scler J Exp Transl Clin. 2019 Jul 23;5(3):2055217319863122.  Link to Publication

Kottaram A, Johnston LA, Cocchi L, Ganella EP, Everall I, Pantelis C, Kotagiri R, Zalesky A. Brain network dynamics in schizophrenia: Reduced dynamism of the default mode network. Hum Brain Mapp. 2019 May; 40(7):2212-28.  Link to Publication

Syeda W, Blunck Y, Kolbe S, Cleary JO, Johnston LA.  A continuum of T2* components: Flexible fast fraction mapping in Sodium MRI. Magn Reson Med. 2019 Jun; 81(6), 3854-3864.                     Link to Publication

Allocca G, Ma S, Martelli D, Cerri M, Del Vecchio F, Bastianini S, Zoccoli G, Amici R, Morairty SR, Aulsebrook AE, Blackburn S, Lesku JA, Rattenborg NC, Vyssotski AL, Wams E, Porcheret K, Wulff K, Foster R, Chan JKM, Nicholas CL, Freestone DR, Johnston LA, Gundlach AL. Validation of ‘Somnivore’, a Machine Learning Algorithm for Automated Scoring and Analysis of Polysomnography Data. Frontiers Neurosci2019 Mar;13:207.  Link to Publication

Immonen R, Harris NG, Wright D, Johnston L, Manninen E, Smith G, Paydar A, Branch C, Grohn O.  Imaging biomarkers of epileptogenecity after traumatic brain injury - preclinical frontiers.  NeurobioloDis.2019 Mar 123:75-85.  Link to Publication

Blunck Y, Moffat BA, Kolbe SC, Ordidge RJ, Cleary JO, Johnston LA. Zero-Gradient-Excitation Ramped Hybrid Encoding (zGRF-RHE) Sodium MRI. Magn Reson Med. 2019 Feb 81(2):1172-1180.   Link to Publication

Immonen R, Smith G, Brady RD, Wright D, Johnston L, Harris NG, Manninen E, Salo R, Branch C, Duncan D, Cabeen R, Ndode-Ekane XE, Gomez CS, Casillas-Espinosa PM, Ali I, Shultz SR, Andrade P, Puhakka N, Staba RJ, O'Brien TJ, Toga AW, Pitkänen A, Gröhn O.  Harmonization of pipeline for preclinical multicenter MRI biomarker discovery in a rat model of post-traumatic epileptogenesis. Epilepsy Res. 2019 Feb; 150:46-57.  Link to Publication

Clough M, Dobbing J, Stankovich J, Ternes A, Kolbe S, White OB, Fielding J. Cognitive processing speed deficits in multiple sclerosis: Dissociating sensorial and motor processing changes from cognitive processing speed. Mult Scler Relat Disord. 2020 Feb;38:101522.  Link to Publication

Perera T, Lee WL, Yohanandan SAC, Nguyen AL, Cruse B, Boonstra FMC, Noffs G, Vogel AP, Kolbe SC, Butzkueven H, Evans A, van der Walt A.  Validation of a precision tremor measurement system for multiple sclerosis. J Neurosci Methods. 2019 Jan; 311: 377 -384.  Link to Publication

Neal A, Moffat BA, Stein JM, Nanga RPR, Desmond P, Shinohara RT, Hariharan H, Glarin R, Drummond K, Morokoff A, Kwan P, Reddy R, O'Brien TJ, Davis KA.  Glutamate weighted imaging contrast in gliomas with 7Tesla magnetic resonance imaging. Neuroimage Clin,2019; 22:101694.   Link to Publication

2018

Noffs G, Perera T, Kolbe SC, Shanahan CJ, Boonstra FMC, Evans A, Butzkueven H, van der Walt A, Vogel AP. What speech can tell us: A systematic review of dysarthria characteristics in Multiple Sclerosis. Autoimmun Rev. 2018 Dec;17(12):1202-1209.  Link to Publication

Yoo PE, Cleary JO, Kolbe SC, Ordidge RJ, O'Brien TJ, Opie NL, John SE, Oxley TJ, Moffat BA. Optimized partial-coverage functional analysis pipeline (OPFAP): a semi-automated pipeline for skull stripping and co-registration of partial-coverage, ultra-high-field functional images. MAGMA.  2018 Oct;31(5):621-632.  Link to Publication

Yoo PE, Oxley TJ, John SE, Opie NL, Ordidge RJ, O'Brien TJ, Hagan MA, Wong YT, Moffat BA. Feasibility of identifying the ideal locations for motor intention decoding using unimodal and multimodal classification at 7T-fMRI. Sci Rep. 2018 Oct 22;8(1):15556.  Link to Publication

Field KM, Fitt G, Rosenthal MA, Simes J, Nowak AK, Barnes EH, Sawkins K, Goh C, Moffat BA, Salinas S, Cher L, Wheeler H, Hovey EJ, Phal PM, CABARET/COGNO Investigators.  Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial. Asia Pac J Clin Oncol. 2018 Oct; 14(5): e359 -e365.  Link to Publication

Kottaram A, Johnston L, Ganella E, Pantelis C, Kotagiri R, Zalesky A.  Spatio-temporal dynamics of resting-state brain networks improve single-subject prediction of schizophrenia diagnosis. Hum Brain Mapp. 2018 Sep; 39(9): 3663 -81 .  Link to Publication

Boonstra FMC, Perera T, Noffs G, Marotta C, Vogel AP, Evans AH, Butzkueven H, Moffat BA, van der Walt A, Kolbe SC. Novel Functional MRI Task for Studying the Neural Correlates of Upper Limb Tremor. Front Neurol. 2018 Jul 9: 513.  Link to Publication

Yoo PE, Hagan MA, John SE, Opie NL, Ordidge RJ, O'Brien TJ, Oxley TJ, Moffat BA, Wong YT.  Spatially dynamic recurrent information flow across long-range dorsal motor network encodes selective motor goals. Hum Brain Mapp. 2018 Jun; 39(6): 2635-2650.                                   Link to Publication

Blunck Y, Josan S, Taqdees SW, Moffat BA, Ordidge RJ, Cleary JO, Johnston LA.  3D-multi-echo radial imaging of 23Na (3D-MERINA) for time-efficient multi-parameter tissue compartment mapping. Magn Reson Med. 2018 Apr; 79 (4): 1950-1961.  Link to Publication

Ly J , Li Y , Vu MN , Moffat BA , Jack KS , Quinn JF , Whittaker MR , Davis TP . Nano-assemblies of cationic mPEG brush block copolymers with gadolinium polyoxotungstate [Gd(W5O18)2]9- form stable, high relaxivity MRI contrast agents. Nanoscale. 2018 Apr 19;10(15):7270-7280.                   Link to Publication

Kumar SS, Moffat BA, Salinas S, Churilov L, Yan B. An Objective Measurement of Lacunar Infarct Location from the Middle Cerebral Artery Stem. J Stroke Cerebrovasc Dis. 2018 Mar; 27 (3):599-605.  Link to Publication

Jenkins LM, Andrewes DG, Nicholas CL, Drummond KJ, Moffat BA, Phal PM, Desmond P. Emotional reactivity following surgery to the prefrontal cortex. J Neuropsychol. 2018 Mar; 12(1):120-141.  Link to Publication

Shanahan CJ, Boonstra FMC, Cofré Lizama LE, Strik M, Moffat BA, Khan F, Kilpatrick TJ, van der Walt A, Galea MP, Kolbe SC.  Technologies for Advanced Gait and Balance Assessments in People with Multiple Sclerosis.  Front. Neurol. 2018 Feb; 8:708.  Link to Publication

Yoo PE, John SE, Farquharson S, Cleary JO, Wong YT, Ng A, Mulcahy CB, Grayden DB, Ordidge RJ, Opie NL, O'Brien TJ, Oxley TJ, Moffat BA. 7T-fMRI: Faster temporal resolution yields optimal BOLD sensitivity for functional network imaging specifically at high spatial resolution. Neuroimage.  2018 Jan; 164:214-229.  Link to Publication

2017

Boonstra F, Florescu G, Evans A, Steward C, Mitchell P, Desmond P, Moffat B, Butzkueven H, Kolbe S, van der Walt A.  Tremor in multiple sclerosis is associated with cerebello-thalamic pathology.  J.Neural Transm (Vienna). 2017Dec: 124(12): 1509-1514.  Link to Publication

Gajamange S, Raffelt D, Dhollander T, Lui E, van der Walt A, Kilpatrick T, Fielding J, Connelly A, Kolbe S. Fibre specific white matter changes in multiple sclerosis patients with optic neuritis. NeuroImage Clin. 2017 Sep; 17: 60-8.  Link to Publication

Wright DK, Liu S, van der Poel C, McDonald SJ, Brady RD, Taylor L, Yang L, Gardner AJ, Ordidge R, O'Brien TJ, Johnston LA, Shultz SR. Traumatic Brain Injury Results in Cellular, Structural and Functional Changes Resembling Motor Neuron Disease. Cereb Cortex. 2017 Sep; 27(9): 4503-4515.  Link to Publication

Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, Maruff P, Villemagne VL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group, Salvado O, Bush AI. Cerebral quantitative susceptibility mapping predicts amyloid-β- related cognitive decline. Brain. 2017 Aug 140(8): 2112-2119.  Link to Publication

Sharma P, Wright DK, Johnston LA, Powell KL, Wlodek ME, Shultz SR, O'Brien TJ, Gilby KL. Differences in white matter structure between seizure prone (FAST) and seizure resistant (SLOW) rat strains. Neurobiol Dis. 2017 Aug;104:33-40.  Link to Publication

Wright DK, Johnston LA, Kershaw J, Ordidge R, O'Brien TJ, Shultz SR.  Changes in Apparent Fiber Density and Track-Weighted Imaging Metrics in White Matter following Experimental Traumatic Brain Injury. J Neurotrauma. 2017 Jul; 34(13):2109-2118.  Link to Publication

Dongworth RK, Campbell-Washburn AE, Cabrera-Fuentes HA, Bulluck H, Roberts T, Price AN, Hernández-Reséndiz S, Ordidge RJ, Thomas DL, Yellon DM, Lythgoe MF, Hausenloy DJ.  Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance. Sci Rep.2017 May 7(1):2271.  Link to Publication

Shelton AL, Cornish KM, Godler D, Bui QM, Kolbe S, Fielding J.  White matter microstructure, cognition, and molecular markers in fragile X premutation females. Neurology. 2017 May; 88(22):2080-2088.  Link to Publication

Tran N, Bye N, Moffat BA, Wright DK, Cuddihy A, Hinton TM, Hawley AM, Reynolds NP, Waddington LJ, Mulet X, Turnley AM, Morganti-Kossmann MC, Muir BW. Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution.  Mater Sci Eng C Mater Biol Appl. 2017 Feb;71:584-593.  Link to Publication

Shelton AL, Cornish K, Clough M, Gajamange S, Kolbe S, Fielding J.  Disassociation between brain activation and executive function in fragile X premutation females. Hum Brain Mapp. 2017 Feb; 38(2): 1056-67.  Link to Publication

Burrows EL, Eastwood AF, May C, Kolbe SC, Hill T, McLachlan NM, Churilov L, Hannan AJ. Social Isolation Alters Social and Mating Behavior in the R451C Neuroligin Mouse Model of Autism. Neural Plast. 2017; 2017:8361290.  Link to Publication

Bennett IE, Field KM, Hovens CM, Moffat BA, Rosenthal MA, Drummond K, Kaye AH, Morokoff AP. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin. J Neurooncol. 2017 Jan: 131 (2):321-329.                                   Link to Publication

2016

Shelton AL, Cornish KM, Kolbe S, Clough M, Slater HR, Li X, Kraan CM, Bui QM, Godler DE, Fielding J.  Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females. TranslPsychiatry. 2016 Dec; 6(12): e984                   Link to Publication

Domínguez JF, Ng AC, Poudel G, Stout JC, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N. Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study. J Neurol Neurosurg Psychiatry. 2016 May;87(5):545-9.  Link to Publication

Tahayori B, Khaneja N, Johnston LA, Farrell PM, Mareels IM. Improving the time efficiency of the Fourier synthesis method for slice selection in magnetic resonance imaging. Phys Med. 2016 Jan;32(1):94-103.  Link to Publication

Swaminathan M, Hill-Yardin E, Ellis M, Zygorodimos M, Johnston LA, Gwynne RM, Bornstein JC. Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice. J Vis Exp. 2016 Feb 3;(108):53828.  Link to Publication

2015

Close TG, Tournier JD, Johnston LA, Calamante F, Mareels I, Connelly A. Fourier Tract Sampling (FouTS): A framework for improved inference of white matter tracts from diffusion MRI by explicitly modelling tract volume. Neuroimage. 2015 Oct 15;120:412-27.  Link to Publication

Phillips TR, Wright DK, Gradie PE, Johnston LA, Pask AJ. A Comprehensive Atlas of the Adult Mouse Penis. Sex Dev. 2015;9(3):162-72.  Link to Publication

Van der Walt A, Buzzard K, Sung S, Spelman T, Kolbe SC, Marriott M, Butzkueven H, Evans A. The occurrence of dystonia in upper-limb multiple sclerosis tremor. Mult Scler. 2015 Dec;21(14):1847-55.  Link to Publication

Shultz SR, Wright DK, Zheng P, Stuchbery R, Liu SJ, Sashindranath M, Medcalf RL, Johnston LA, Hovens CM, Jones NC, O'Brien TJ. Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury. Brain. 2015 May;138(Pt 5):1297-313.                   Link to Publication

van der Walt A, Kolbe S, Mitchell P, Wang Y, Butzkueven H, Egan G, Yiannikas C, Graham S, Kilpatrick T, Klistorner A. Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis. PLoS One. 2015 May 28;10(5):e0121084.  Link to Publication

Warner CE, Kwan WC, Wright D, Johnston LA, Egan GF, Bourne JA. Preservation of vision by the pulvinar following early-life primary visual cortex lesions. Curr Biol. 2015 Feb 16;25(4):424-34. doi: 10.1016/j.cub.2014.12.028.  Link to Publication

2014

Adlard PA, Tran BA, Finkelstein DI, Desmond PM, Johnston LA, Bush AI, Egan GF. A review of β-amyloid neuroimaging in Alzheimer's disease. Front Neurosci. 2014 Oct 31;8:327.                     Link to Publication

Layton KJ, Tahayori B, Mareels IM, Farrell PM, Johnston LA. Rabi resonance in spin systems: theory and experiment. J Magn Reson. 2014 May;242:136-42.  Link to Publication

Shultz SR, Tan XL, Wright DK, Liu SJ, Semple BD, Johnston L, Jones NC, Cook AD, Hamilton JA, O'Brien TJ. Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury. J Neurotrauma. 2014 May 15;31(10):976-83.                           Link to Publication

Crack PJ, Zhang M, Morganti-Kossmann MC, Morris AJ, Wojciak JM, Fleming JK, Karve I, Wright D, Sashindranath M, Goldshmit Y, Conquest A, Daglas M, Johnston LA, Medcalf RL, Sabbadini RA, Pébay A. Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes. J Neuroinflammation. 2014 Feb 27;11:37.   Link to Publication

Liang X, Kuhlmann L, Johnston LA, Grayden DB, Vogrin S, Crossley R, Fuller K, Lourensz M, Cook MJ. Extending communication for patients with disorders of consciousness. J Neuroimaging. 2014 Jan-Feb;24(1):31-8.  Link to Publication

2013

Spitz G, Maller JJ, Ng A, O'Sullivan R, Ferris NJ, Ponsford JL. Detecting lesions after traumatic brain injury using susceptibility weighted imaging: a comparison with fluid-attenuated inversion recovery and correlation with clinical outcome. J Neurotrauma. 2013 Dec 15;30(24):2038-50.   Link to Publication

Adamson C, Johnston L, Mareels I, Toga A, Huang X, Egan G.  3D model-based approach to identification of laminar structures of the cerebral cortex: Application to Brodmann areas 17 and 18.  Biomedical Signal Processing and Control. 2013 Nov. 8(6): 845-857.  Link to Publication

Georgiou-Karistianis N, Gray MA, Domínguez D JF, Dymowski AR, Bohanna I, Johnston LA, Churchyard A, Chua P, Stout JC, Egan GF. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study. Neurobiol Dis. 2013 Mar;51:82-92.  Link to Publication

Davey CE, Grayden DB, Gavrilescu M, Egan GF, Johnston LA. The equivalence of linear Gaussian connectivity techniques. Hum Brain Mapp. 2013 Sep;34(9):1999-2014.  Link to Publication

Davey CE, Grayden DB, Egan GF, Johnston LA. Filtering induces correlation in fMRI resting state data. Neuroimage. 2013 Jan 1;64:728-40.  Link to Publication

2012

Kolbe S, Bajraszewski C, Chapman C, Nguyen T, Mitchell P, Paine M, Butzkueven H, Johnston L, Kilpatrick T, Egan G. Diffusion tensor imaging of the optic radiations after optic neuritis. Hum Brain Mapp. 2012 Sep;33(9):2047-61.  Link to Publication

Layton KJ, Morelande M, Farrell PM, Moran B, Johnston LA. Performance analysis for magnetic resonance imaging with nonlinear encoding fields. IEEE Trans Med Imaging. 2012 Feb;31(2):391-404.  Link to Publication

Slee MG, Rainey-Smith SR, Villemagne VL, Doecke JD, Sohrabi HR, et.al. Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults. Alzheimers Dement. 2024 Feb;20(2):1350-1359.  Link to Publication

Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, et.al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Commun. 2023 Oct 18;5(6):fcad280. Link to Publication

Tosun D, Yardibi O, Benzinger TLS, Kukull WA, Masters CL, Perrin RJ, Weiner MW, Simen A, Schwarz AJ; Alzheimer's Disease Neuroimaging Initiative. Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease. Alzheimers Dement. 2023 Sep 4.  Link to Publication

McKay NS, Gordon BA, Hornbeck RC, Dincer A, et.al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nat Neurosci. 2023 Aug;26(8):1449-1460.    Link to Publication

Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S,.  et.al. Longitudinal head-to-head comparison of ¹¹C-PiB and ¹⁸F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682.  Link to Publication

Feizpour A, Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, etal. Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum. J Prev Alzheimers Dis. 2023;10(4):828-836.  Link to Publication

Bourgeat P, Doré V, Rowe CC, Benzinger T, Tosun D, Goyal MS, LaMontagne P, Jin L, Weiner MW, Masters CL, Fripp J, Villemagne VL; Alzheimer's Disease Neuroimaging Initiative; OASIS3, and the AIBL research group. A universal neocortical mask for Centiloid quantification. Alzheimers Dement (Amst). 2023 Jul 21;15(3):e12457. Link to Publication

Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, et.al.; Alzheimer's Disease Neuroimaging Initiative and the AIBL research group. CenTauR: Toward a universal scale and masks for standardizing tau imaging studies. Alzheimers Dement (Amst). 2023 Jul 7;15(3):e12454.  Link to Publication

Cummins TL, Doré V, Feizpour A, Krishnadas N, Bourgeat P, Elias A, Lamb F, Williams R, Hopwood M, Landau S, Villemagne VL, Weiner M, Rowe CC. Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS). J Neurotrauma. 2023 Jun;40(11-12):1086-1097.  Link to Publication

Chin KS, Gajamange S, Desmond PM, Villemagne VL, Rowe CC, Churilov L, Yassi N, Watson R. Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies. Aust N Z J Psychiatry. 2023 Apr;57(4):594-602.  Link to Publication

Chatterjee P, Doré V, Pedrini S, Krishnadas N, Thota R, Bourgeat P, Ikonomovic MD, Rainey-Smith SR, Burnham SC, Fowler C, Taddei K, Mulligan R, Ames D, Masters CL, Fripp J, Rowe CC, Martins RN, Villemagne VL; The AIBL Research Group. Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease. J Alzheimers Dis. 2023;92(2):615-628.   Link to Publication

Winston CN, Langford O, Levin N, Raman R, Yarasheski K, et al. Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease. J Alzheimers Dis. 2023;92(1):95-107.  Link to Publication

Krishnadas N, Doré V, Robertson JS, Ward L, Fowler C, Masters CL, Bourgeat P, Fripp J, Villemagne VL, Rowe CC. Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study. EBioMedicine. 2023 Feb;88:104450.                             Link to Publication

Vöglein J, Franzmeier N, Morris JC, Dieterich M, McDade E, et al. Dominantly Inherited Alzheimer Network. Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimers Dement. 2023 Feb;19(2):632-645.   Link to Publication

Bourgeat P, Krishnadas N, Doré V, Mulligan R, Tyrrell R, Bozinovski S, Huang K, Fripp J, Villemagne VL, Rowe CC. Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden. J Prev Alzheimers Dis. 2023;10(2):251-258.    Link to Publication

Roberts BR, Laffoon SB, Roberts AM, Porter T, Fowler C, Masters CL, Dratz EA, Laws SM. Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study. J Alzheimers Dis Rep. 2023 Feb 24;7(1):165-172.    Link to Publication

Sewell KR, Rainey-Smith SR, Villemagne VL, Peiffer J, Sohrabi HR, et al. The interaction between physical activity and sleep on cognitive function and brain beta-amyloid in older adults. Behav Brain Res. 2023 Feb 2;437:114108. Link to Publication

Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. Lancet Neurol. 2023 Jan;22(1):55-65.    Link to Publication

Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, Rowe CC, Masters CL, Ames D, Blennow K, Zetterberg H, Martins RN, Gupta V. Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals. Alzheimers Dement (Amst). 2022 Dec 4;14(1):e12377. Link to Publication

Fowler CJ, Stoops E, Rainey-Smith SR, Vanmechelen E.et al. Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline. Alzheimers Dement (Amst). 2022 Nov 25;14(1):e12375.   Link to Publication

Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, Stomrud E, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022 Nov;28(11):2381-2387.       Link to Publication

Huang X, Li Y, Fowler C, Doecke JD, Lim YY, Drysdale C, Zhang V, Park K, Trounson B et al. Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease. Alzheimers Dement. 2022 Nov 9.   Link to Publication

Chin KS, Hijazi Z, Churilov L, Gajamange S, Desmond PM, Villemagne V, Rowe C, Yassi N, Watson R. Cerebral microbleeds in dementia with Lewy bodies. Parkinsonism Relat Disord. 2022 Nov;104:68-71.  Link to Publication

Bourgeat P, Doré V, Burnham SC, Benzinger T, Tosun D, Li S, Goyal M, LaMontagne P, Jin L, Rowe CC, et al. Alzheimer's Disease Neuroimaging Initiative, OASIS3, and the AIBL research group. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3. Neuroimage. 2022 Nov 15;262:119527.  Link to Publication

Villemagne VL, Harada R, Doré V, Furumoto S, Mulligan R, Kudo Y, Burnham S, Krishnadas N, et al. Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum. J Nucl Med. 2022 Oct;63(10):1560-1569.   Link to Publication

Villemagne VL, Harada R, Doré V, Furumoto S, Mulligan R, Kudo Y, Burnham S, Krishnadas N, et al. First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis. J Nucl Med. 2022 Oct;63(10):1551-1559.  Link to Publication

Pedrini S, Doecke JD, Hone E, Wang P, Thota R, Bush AI, Rowe CC, Dore V, Villemagne VL, Ames D, et al. Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. J Neurochem. 2022 Oct;163(1):53-67.   Link to Publication

Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, et al. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. JAMA Neurol. 2022 Oct 1;79(10):975-985.   Link to Publication

Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T, Fladby T, Molinuevo JL, et al. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimers Dement. 2022 Oct;18(10):1832-1845.   Link to Publication

Hicks AJ, Ponsford JL, Spitz G, Dore V, Krishnadas N, Roberts C, Rowe CC. β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury: A Cross-sectional Study. Neurology. 2022 Sep 13;99(11):e1131-e1141.   Link to Publication

Cespedes M, Jacobs KR, Maruff P, Rembach A, Fowler CJ, Trounson B, Pertile KK, Rumble RL, Rainey-Smithe SR, Rowe CC, Villemagne VL, Bourgeat P, Lim CK, Chatterjee P, Martins RN, Ittner A, Masters CL, Doecke JD, Guillemin GJ, Lovejoy DB. Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β. Neurobiol Dis. 2022 Sep;171:105783. Link to Publication

Ruwanpathirana GP, Williams RC, Masters CL, Rowe CC, Johnston LA, Davey CE. Mapping the association between tau-PET and Aβ-amyloid-PET using deep learning. Sci Rep. 2022 Aug 30;12(1):14797.   Link to Publication

Kellie JF, Campbell BCV, Watson R, Praeger AJ, Nair G, Murugasu A, Rowe CC, Masters CL, Collins S, McLean C, Yassi N. Amyloid-β (Aβ)-Related Cerebral Amyloid Angiopathy Causing Lobar Hemorrhage Decades After Childhood Neurosurgery. Stroke. 2022 Aug;53(8):e369-e374.     Link to Publication

Krishnadas N, Doré V, Laws SM, Porter T, Lamb F, Bozinovski S, Villemagne VL, Rowe CC. Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases. Alzheimers Dement (Amst). 2022 Aug 26;14(1):e12326.   Link to Publication

Hicks AJ, Spitz G, Rowe CC, Roberts CM, McKenzie DP, Ponsford JL. Does cognitive decline occur decades after moderate to severe traumatic brain injury? A prospective controlled study. Neuropsychol Rehabil. 2022 Aug;32(7):1530-1549.   Link to Publication

Krishnadas N, Huang K, Schultz SA, Doré V, Bourgeat P, Goh AMY, Lamb F, Bozinovski S, Burnham SC, et al. Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease. J Alzheimers Dis. 2022;88(4):1627-1637.  Link to Publication

Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Doré V, Singh AK, Wang P, Rainey-Smith S, et al. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2022 Jul 21. Link to Publication

Li Y, Huang X, Fowler C, Lim YY, Laws SM, Faux N, Doecke JD, Trounson B, Pertile K, Rumble R, Doré V, et al. Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease. Int J Mol Sci. 2022 Jul 17;23(14):7867. Link to Publication

Woodward M, Brodaty H, McCabe M, Masters CL, Naismith SL, Morris P, Rowe CC, Walker P, Yates M. Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment. J Alzheimers Dis. 2022;89(3):803-809.  Link to Publication

Milicic L, Vacher M, Porter T, Doré V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Australian Imaging Biomarkers and Lifestyle (AIBL) Study. Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume. Geroscience. 2022 Jun;44(3):1807-1823.   Link to Publication

Spitz G, Hicks AJ, Roberts C, Rowe CC, Ponsford J. Brain age in chronic traumatic brain injury. Neuroimage Clin. May 2022;35:103039.   Link to Publication

Vacher M, Doré V, Porter T, Milicic L, Villemagne VL, Bourgeat P, Burnham SC, Cox T, Masters CL, Rowe CC, Fripp J, Doecke JD, Laws SM. Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's disease. BMC Genomics. 2022 May 26;23(1):401.  Link to Publication

Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Blennow K, Zetterberg H, Martins RN, Gupta V. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study. Biomedicines. 2022 Apr 30;10(5):1045.   Link to Publication

Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Krishnadas N, Bourgeat P, Huang K, Burnham S, Fowler C, Rainey-Smith SR, Bush AI, Ward L, Robertson J, Martins RN, Masters CL, Villemagne VL, Fripp J, Kolb HC, Rowe CC. Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. Alzheimers Dement (Amst). 2022 Apr 5;14(1):e12307.  Link to Publication

Krishnadas N, Doré V, Groot C, Lamb F, Bourgeat P, Burnham SC, Huang K, Goh AMY, Masters CL, Villemagne VL, Rowe CC; AIBL research group. Mesial temporal tau in amyloid-β-negative cognitively normal older persons. Alzheimers Res Ther. 2022 Apr 8;14(1):51.   Link to Publication

Yu Y, Robinson DL, Ackland DC, Yang Y, Lee PVS. Influence of the geometric and material properties of lumbar endplate on lumbar interbody fusion failure: a systematic review. J Orthop Surg Res. 2022 Apr 10;17(1):224.  Link to Publication

Rosenich E, Bransby L, Yassi N, Fripp J, Laws SM, Martins RN, Fowler C, Rainey-Smith SR, Rowe CC, Masters CL, Maruff P, Lim YY. Differential Effects of APOE and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ- and Aβ+ Older Adults. Neurology. 2022 Apr 26;98(17):e1704-e1715.  Link to Publication

Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ; Amyloid Biomarker Study Group; et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 2022 Mar 1;79(3):228-243.  Erratum in: JAMA Neurol. 2022 Mar 1;79(3):313.  Link to Publication

Pedrini S, Chatterjee P, Nakamura A, Tegg M, Hone E, Rainey-Smith SR, Rowe CC, Dore V, Villemagne VL, et al. The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults. Front Aging Neurosci. 2022 Mar 28;14:771214.                    Link to Publication

Shishegar R, Cox T, Rolls D, Bourgeat P, Doré V, Lamb F, Robertson J, Laws SM, Porter T, Fripp J, Tosun D, Maruff P, Savage G, Rowe CC, Masters CL, Weiner MW, Villemagne VL, Burnham SC. Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI. Sci Rep. 2021 Dec 10;11(1):23788. Link to Publication

Li S, O'Keefe G, Gillman A, Burnham SC, Masters CL, Williams R, Rowe CC, Fripp J, Bourgeat P, Villemagne VL, Dore V.  Investigating the impact of scatter correction on Centiloid;  Alzheimers and Dementia – J of the Alz. Association. 17(S1) Alzheimer's Imaging Consortium December 2021 e053822 POSTER PRESENTATION Link to Publication

Doré V, Krishnadas N, Bourgeat P, Huang K, Li S, Burnham S, Masters CL, Fripp J, Villemagne VL, Rowe CC. Relationship between amyloid and tau levels and its impact on tau spreading. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2225-2232. Link to Publication

Bucci M, Savitcheva I, Farrar G, Salvadó G, Collij L, Doré V, Gispert JD, Gunn R, Hanseeuw B, Hansson O, Shekari M, Lhommel R, Molinuevo JL, Rowe C, Sur C, Whittington A, Buckley C, Nordberg A. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2183-2199.  Link to Publication

Fowler C, Rainey-Smith SR, Bird S, Bomke J, Bourgeat P, et.al. Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease. J Alzheimers Dis Rep. 2021 Jun 3;5(1):443-468. Link to Publication

Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol. 2021 Jun;20(6):484-496.  Link to Publication

Krishnadas N, Villemagne VL, Doré V, Rowe CC. Advances in Brain Amyloid Imaging. Semin Nucl Med. 2021 May;51(3):241-252.  Link to Publication https://pubmed.ncbi.nlm.nih.gov/33482999/

Bullich S, Roé-Vellvé N, Marquié M, Landau SM, Barthel H, Villemagne VL, Sanabria Á, Tartari JP, Sotolongo-Grau O, Doré V, Koglin N, Müller A, Perrotin A, Jovalekic A, De Santi S, Tárraga L, Stephens AW, Rowe CC, Sabri O, Seibyl JP, Boada M. Early detection of amyloid load using 18F-florbetaben PET. Alzheimers Res Ther. 2021 Mar 27;13(1):67.    Link to Publication

Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment. J Int Neuropsychol Soc. 2021 Feb;27(2):146-157.  Link to Publication

Bourgeat P, Doré V, Doecke J, Ames D, Masters CL, Rowe CC, Fripp J, Villemagne VL; AIBL research group. Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies. Neuroimage. 2021 Feb 1;226:117593.  Link to Publication

van der Kall LM, Truong T, Burnham SC, Doré V, Mulligan RS, Bozinovski S, Lamb F, Bourgeat P, Fripp J, Schultz S, Lim YY, Laws SM, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Maruff P, Masters CL, Villemagne VL, Rowe CC. Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals. Neurology. 2021 Feb 2;96(5):e662-e670.  Link to Publication

Ruwanpathirana GP, Plett DC, Williams RC, Davey CE, Johnston LA, Kronzucker HJ. Continuous monitoring of plant sodium transport dynamics using clinical PET. Plant Methods. 2021 Jan 19;17(1):8. doi: 10.1186/s13007-021-00707-8. PMID: 33468197; PMCID: PMC7814562.                     Link to Publication

Groot C, Doré V, Robertson J, Burnham SC, Savage G, Ossenkoppele R, Rowe CC, Villemagne VL. Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β-negative cognitively normal individuals. Neurobiol Aging. 2021 Jan;97:41-48.             Link to Publication

Villemagne VL., Doré, V, Burnham S, Rowe CC. Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions Chapter in book:  PET and SPECT in Neurology, Springer International Publishing, pgs  283-343.

Krishnadas N, Doré V, Lamb F, Groot C, McCrory P, Guzman R, Mulligan R, Huang K, O'Donnell M, Ponsford J, Hopwood M, Villemagne VL, Rowe CC. Case Report: 18F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player. Front Neurol. 2020 Dec 22;11:598980.  Link to Publication

Villemagne VL, Lopresti BJ, Dore V, Tudorascu D, Ikonomovic MD, Burnham S, Minhas D, Pascoal TA, Mason NS, Snitz B, Aizenstein H, Mathis CA, Lopez O, Rowe CC, Klunk WE, Cohen AD. What is T+? A Gordian Knot of Tracers, Thresholds & Topographies. J Nucl Med. 2020 Dec 31: jnumed.120.245423.  Link to Publication

Huynh K, Lim WLF, Giles C, Jayawardana KS, Salim A, Mellett NA, Smith AAT, Olshansky G, Drew BG, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Arnold M, Nho K, Saykin AJ, Baillie R, Han X, Kaddurah-Daouk R, Martins RN, Meikle PJ. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. Nat Commun. 2020 Nov 10;11(1):5698.  Link to Publication

Burnham SC, Laws SM, Budgeon CA, Doré V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA, Salvado O, Ames D, Martins RN, Rentz D, Masters CL, Rowe CC, Villemagne VL. Alzheimer's Disease Neuroimaging Initiative; AIBL Research Group. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition. Neurobiol Aging. 2020 Nov; 95:46-55.  Link to Publication

Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, Kato T, Rowe CC, Arahata Y, Iwamoto S, Ito K, Tanaka K, Yanagisawa K, Masters CL, Nakamura A. Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease. J Alzheimers Dis. Sep 2020; 77(3):1057-1065.  Link to Publication

Lin X, Wallis K, Ward SA, Brodaty H, Sachdev PS, Naismith SL, Krysinska K, McNeil J, Rowe CC, Ahern S. The protocol of a clinical quality registry for dementia and mild cognitive impairment (MCI): the Australian dementia network (ADNeT) Registry. BMC Geriatr. 2020 Sep 7;20(1):330.   Link to Publication

Miles LF, Chuen J, Edwards L, Hohmann JD, Williams R, Peyton P, Grayden DB. The design and manufacture of 3D-printed adjuncts for powered air-purifying respirators. Anaesth Rep. 2020 Jul 19; 8(2):e12055.  Link to Publication

Nadebaum DP, Krishnadas N, Poon AM, Kalff V, Lichtenstein M, Villemagne VL, Jones G, Rowe CC.  A head-to-head comparison of cerebral blood flow SPECT and (18) F-FDG PET in the diagnosis of Alzheimer's Disease. Intern Med J. 2020 May 10.  Link to Publication

Huynh K, Lim WLF, Giles C, Jayawardana KS, Salim A, Mellett NA, Smith A, Olshansky G,Drew BG, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Villemagne VL , Ames D, Masters CL, Arnold M , Nho K, Saykin AJ, Baillie R, Han X, Kaddurah-Daouk R, Martins RN, Meikle PJ.  Combining two large clinical cohorts (AIBL and ADNI) to identify multiple lipid metabolic pathways in prevalent and incident Alzheimer’s disease.  medRxiv; 2020 May: 20114215.  Link to Publication

Venkatraman VK, Sanderson A, Cox KL, Ellis KA, Steward C, Phal PM, Gorelik A, Sharman MJ, Villemagne VL, Lai M, Cyarto EV, Merkel B, Ames D, Szoeke C, Rowe CC, Masters CL, Lautenschlager NT, Desmond PM. Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial. Neurobiol Aging. 2020 May; 89:132-141.  Link to Publication

Venkatraman VK, Steward CE, Cox KL, Ellis KA, Phal PM, Sharman MJ, Villemagne VL, Lai MMY, Cyarto EV, Ames D, Szoeke C, Rowe CC, Masters CL, Lautenschlager NT, Desmond PM. Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer's Disease. Front Aging Neurosci. 2020 Apr 29;12:115.  Link to Publication

Burnham SC, Fandos N, Fowler C, Pérez-Grijalba V, Dore V, Doecke JD, Shishegar R, Cox T, Fripp J, Rowe C, Sarasa M, Masters CL, Pesini P, Villemagne VL. Longitudinal evaluation of the natural history of amyloid-β in plasma and brain. Brain Commun. 2020 Apr 14;2(1):fcaa041.                     Link to Publication

Amadoru S, Doré V, McLean CA, Hinton F, Shepherd CE, Halliday GM, Leyton CE, Yates PA, Hodges JR, Masters CL, Villemagne VL, Rowe CC. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease. Alzheimers Res Ther. 2020 Mar;12(1):22.   Link to Publication

Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE; Collaborators from the Harvard Aging Brain Study, the Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging, Biomarker and Lifestyle Study of Aging. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimers Dement. 2020 Mar;16(3):552-560.  Link to Publication

Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease. J Magn Reson Imaging. 2020 Feb;51(2):505-513.                                 Link to Publication

Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe CC, Villemagne VL, Salvado O, Desmond PM, Masters CL. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-beta on Alzheimer's Disease. J Alzheimers Dis. 2020 Feb; 73(3):897-907.  Link to Publication

Elias A, Cummins T, Lamb F, Tyrrell R, Dore V, Williams R, Rosenfeld JV, Hopwood M, Villemagne VL, Rowe CC. Amyloid-β, Tau, and 18F-Fluorodeoxyglucose Positron Emission Tomography in Posttraumatic Stress Disorder. J Alzheimers Dis. 2020 Jan ;73(1):163-173.  Link to Publication

2019

Burnham SC, Loi SM, Doecke J, Fedyashov V, Dore V, Villemagne VL, Masters CL. The dawn of robust individualised risk models for dementia. Lancet Neurol. 2019 Nov;18(11):985-987.           Link to Publication

Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, Nakaya T, Meijer L, Maeda M, Yamamoto T, Masters CL, Rowe CC, Ames D, Yamamoto K, Martins RN, Gandy S, Suzuki T. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimers Dement (N Y). 2019 Nov 7;5:740-750.                       Link to Publication

Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, Hassenstab J, Bateman RJ, Morris JC; Dominantly Inherited Alzheimer Network. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimers Dement. 2019 Nov;15(11):1448-1457.   Link to Publication

Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM. Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition. Sci Rep. 2019 Nov 19;9(1):17069.  Link to Publication

Baker JE, Pietrzak RH, Laws SM, Ames D, Villemagne VL, Rowe CC, Masters CL, Maruff P, Lim YY. Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults. Neuropsychology. 2019 Oct;33(7):964-974.  Link to Publication

Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimers Dement (Amst). 2019 Sep 25;11:670-678.  Link to Publication

Carr SJA, Jaeger J, Bian S, He P, Maserejian N, Wang W, Maruff P, Enayetallah A, Wang Y, Chen Z, Lerner A, Tatsuoka C; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Associating Cognition With Amyloid Status Using Partially Ordered Set Analysis. Front Neurol. 2019 Sep 13;10:976.  Link to Publication

Dang C, Yassi N, Harrington KD, Xia Y, Lim YY, Ames D, Laws SM, Hickey M, Rainey-Smith S, Sohrabi HR, Doecke JD, Fripp J, Salvado O, Snyder PJ, Weinborn M, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group. Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance. Alzheimers Dement (Amst). 2019 Aug 12; 11: 566 - 575  Link to Publication

Villemagne VL, Doré V, Burnham S. The trinity of tau, trauma, and time. Lancet Neurol. 2019 Aug;18(8):715-717.  Link to Publication

Cox KL, Cyarto EV, Ellis KA, Ames D, Desmond P, Phal P, Sharman MJ, Szoeke C, Rowe CC, Masters CL, You E, Burrows S, Lai MMY, Lautenschlager NT. A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study. J Alzheimers Dis. 2019 Aug; 70(s1):S187-S205    Link to Publication

Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P for the AIBL Research Group. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600.  Link to Publication

Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.  Arch Clin Neuropsychol. 2019 Jul 26;34(5):585-598.  Link to Publication

Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S. Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology. Alzheimers Dement. 2019 Jun;15(6):807-816.                             Link to Publication

Taswell C, Donohue C, Mastwyk MT, Louey AG, Giummarra J, Robertson J, Darby DG, Masters CL, Rowe CC. Avoiding methodological bias in studies of amyloid imaging results disclosure. Alzheimers Res Ther. 2019 Jun 4;11(1):52.  Link to Publication

Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, Jacobs HIL, Papp KV, Amariglio RE, Properzi MJ, Schultz AP, Kirn D, Scott MR, Hedden T, Farrell M, Price J, Chhatwal J, Rentz DM, Villemagne VL, Johnson KA, Sperling RA. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults. JAMA Neurol. 2019 May 1;76(5):542-551.  Link to Publication

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM. COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults. IBRO Rep. 2019 May 2;6:147-152.                 Link to Publication

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiol Aging. 2019 Apr;76:162-165.  Link to Publication

Liedes H, Lötjönen J, Kortelainen JM, Novak G, van Gils M, Gordon MF; Alzheimer’s Disease Neuroimaging Initiative; the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Multivariate Prediction of Hippocampal Atrophy in Alzheimer's Disease. J Alzheimers Dis. 2019 Apr ;68(4):1453-1468.  Link to Publication

Burnham SC, Coloma PM, Li QX, Collins S, Savage G, Laws S, Doecke J, Maruff P, Martins RN, Ames D, Rowe CC, Masters CL, Villemagne VL. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. J Prev Alzheimers Dis. 2019;6(4):248-255.  Link to Publication

Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Aarsland D, Powell J, Lovestone S, Martins R, Hye A. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. Sci Adv. 2019 Feb 6;5(2):eaau7220.  Link to Publication

La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C Jr, Jagust WJ, Jin LW, Klunk WE, Kofler J, Lesman-Segev OH, Lockhart SN, Lowe VJ, Masters CL, Mathis CA, McLean CL, Miller BL, Mungas D, O'Neil JP, Olichney JM, Parisi JE, Petersen RC, Rosen HJ, Rowe CC, Spina S, Vemuri P, Villemagne VL, Murray ME, Rabinovici GD. Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement. 2019 Feb; 15(2):205-216.  Link to Publication

Jagust W, Jack CR Jr, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Sperling R. "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimers Dement. 2019 Jan;15(1):153-157.  Link to Publication

2018

Battle MR, Pillay LC, Lowe VJ, Knopman D, Kemp B, Rowe CC, Doré V, Villemagne VL, Buckley CJ. Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods. EJNMMI Res. 2018 Dec 5;8(1):107.  Link to Publication

Bourgeat P, Doré V, Fripp J, Ames D, Masters CL, Salvado O, Villemagne VL, Rowe CC; AIBL research group. Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL. Neuroimage. 2018 Dec;183:387-393.  Link to Publication

Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, Fox NC, Sanchez-Valle R, Grau-Rivera O, Gelpi E, Seelaar H, Papma JM, van Swieten JC, Hodges JR, Leyton CE, Piguet O, Rogalski EJ, Mesulam MM, Koric L, Nora K, Pariente J, Dickerson B, Mackenzie IR, Hsiung GR, Belliard S, Irwin DJ, Wolk DA, Grossman M, Jones M, Harris J, Mann D, Snowden JS, Chrem-Mendez P, Calandri IL, Amengual AA, Miguet-Alfonsi C, Magnin E, Magnani G, Santangelo R, Deramecourt V, Pasquier F, Mattsson N, Nilsson C, Hansson O, Keith J, Masellis M, Black SE, Matías-Guiu JA, Cabrera-Martin MN, Paquet C, Dumurgier J, Teichmann M, Sarazin M, Bottlaender M, Dubois B, Rowe CC, Villemagne VL, Vandenberghe R, Granadillo E, Teng E, Mendez M, Meyer PT, Frings L, Lleó A, Blesa R, Fortea J, Seo SW, Diehl-Schmid J, Grimmer T, Frederiksen KS, Sánchez-Juan P, Chételat G, Jansen W, Bouchard RW, Laforce RJ, Visser PJ, Ossenkoppele R. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Ann Neurol. 2018 Nov;84(5):729-740.  Link to Publication

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM; AIBL Research Group. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. J Alzheimers Dis. 2018 Nov;66(3):1193-1211.  Link to Publication

Xu SS, Alexander PK, Lie Y, Dore V, Bozinovski S, Mulligan RS, Young K, Villemagne VL, Rowe CC. Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients. BMJ Open. 2018 Nov 15;8(11):e025533.  Link to Publication

Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, Ellis KA, Martins R, Ames D, Silbert B, Vanderstichele H, Masters CL, Darby DG, Li QX, Collins S; AIBL Research Group. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms. J Alzheimers Dis. 2018 Nov ; 61(1):169-183.  Link to Publication

Elias A, Cummins T, Tyrrell R, Lamb F, Dore V, Williams R, Rosenfeld JV, Hopwood M, Villemagne VL, Rowe CC. Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging. J Alzheimers Dis. 2018  Oct;66(2):733-741.  Link to Publication

Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group. Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease. Neurobiol Aging. 2018 Oct;70:170-179.  Link to Publication

Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, Masters CL, Rowe CC, Martins RN. Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study. Psychol Assess. 2018 Oct;30(10):1308-1316.  Link to Publication

Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, Salvado O, Rowe CC, Scarmeas N, Martins RN. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Transl Psychiatry. 2018 Oct 30;8(1):238.  Link to Publication

Bhagwat N, Viviano JD, Voineskos AN, Chakravarty MM; Alzheimer’s Disease Neuroimaging Initiative. Modeling and prediction of clinical symptom trajectories in Alzheimer's disease using longitudinal data. PLoS Comput Biol. 2018 Sep 14;14(9):e1006376.  Link to Publication

Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, Maruff P, Donohue MC, Rentz DM, Kirn D, Hedden T, Chhatwal J, Schultz AP, Johnson KA, Villemagne VL, Sperling RA; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging, Biomarker and Lifestyle study of ageing; Harvard Aging Brain Study. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement. 2018 Sep;14(9):1193-1203.  Link to Publication

Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults. J Alzheimers Dis. 2018 Sep;65(4):1313-1325.  Link to Publication

Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nat Rev Neurol. 2018 Jul;14(7):446.  Link to Publication

Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, Brodtmann A, Rowe CC, Villemagne VL, Connelly A. Reply: Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease? Brain. 2018 Jun 1;141(6):e45.  Link to Publication

Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography. J Alzheimers Dis. 2018 MAy; 63(4):1299-1305.  Link to Publication

Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. JAMA Neurol. 2018 Apr 1;75(4):488-494.  Link to Publication

Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, Brodtmann A, Rowe CC, Villemagne VL, Connelly A. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment. Brain. 2018 Mar 1;141(3):888-902.  Link to Publication

Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, Gupta S, O'Bryant S, Rembach A, Ames D, Ellis K, Fuller SJ, Brown B, Gardener SL, Fernando B, Bharadwaj P, Burnham S, Laws SM, Barron AM, Goozee K, Wahjoepramono EJ, Asih PR, Doecke JD, Salvado O, Bush AI, Rowe CC, Gandy SE, Masters CL. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. J Alzheimers Dis. 2018 Mar;62(3):965-992.  Link to Publication

Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL research group. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease. J Affect Disord. 2018 Mar 15;229:269-274  Link to Publication

Tomadesso C, de La Sayette V, de Flores R, Bourgeat P, Villemagne VL, Egret S, Eustache F, Chételat G. Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients. Alzheimers Dement (Amst). 2018 Mar 17;10:269-277.  Link to Publication

Lee H, Seo S, Lee SY, Jeong HJ, Woo SH, Lee KM, Lee YB, Park KH, Heo JH, Yoon CW, Kang JM, Cho J, Okamura N, Furumoto S, Yanai K, Na DL, Ido T, Villemagne VL, Noh Y. [18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia. Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):62-69.  Link to Publication

Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 2018 Feb 8;554(7691):249-254.  Link to Publication

McCluskey GE, Yates P, Villemagne VL, Rowe C, Szoeke CEI. Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project. Brain Imaging Behav. 2018 Feb;12(1):78-86.  Link to Publication

Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, Verdile G, Villemagne VL, Laws SM. KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden. Sci Rep. 2018 Feb 1;8(1):2034.  Link to Publication

Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, Martins RN, Laws SM; AIBL Research Group. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Transl Psychiatry. 2018 Feb 26;8(1):47.                   Link to Publication

Acevedo KM, Hayne DJ, McInnes LE, Noor A, Duncan C, Moujalled D, Volitakis I, Rigopoulos A, Barnham KJ, Villemagne VL, White AR, Donnelly PS. Effect of Structural Modifications to Glyoxal-bis(thiosemicarbazonato)copper(II) Complexes on Cellular Copper Uptake, Copper-Mediated ATP7A Trafficking, and P-Glycoprotein Mediated Efflux. J Med Chem. 2018 Feb 8;61(3):711-723.  Link to Publication

Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Pietrzak RH, Maruff P; Australian Imaging, Biomarkers and Lifestyle Research Group. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. Int J Geriatr Psychiatry. 2018 Feb;33(2):405-413.  Link to Publication

Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, Maruff P, Masters CL, Salvado O, Rowe CC, Martins RN; AIBL Research Group. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β. J Alzheimers Dis. 2018 Jan; 61(4):1589-1598.  Link to Publication

Baker JE, Lim YY, Jaeger J, Ames D, Lautenschlager NT, Robertson J, Pietrzak RH, Snyder PJ, Villemagne VL, Rowe CC, Masters CL, Maruff P. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease. J Alzheimers Dis. 2018;65(3):977-988.  Link to Publication

2017

Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN; AIBL Research Group. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Sci Rep. 2017 Oct 25;7(1):14057.  Link to Publication

Fandos N, Pérez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, Doecke J, Fowler C, Masters CL, Sarasa M; AIBL Research Group. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst). 2017 Sep 12;8:179-187.  Link to Publication

Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P; AIBL Research Group. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. J Alzheimers Dis. 2017 Jun;58(4):1293-1302.  Link to Publication

Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group. Amyloid burden and incident depressive symptoms in cognitively normal older adults. Int J Geriatr Psychiatry. 2017 Apr;32(4):455-463.  Link to Publication

Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN; AIBL Research Group. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimers Dement (Amst). 2017 Apr 23;8:60-72.  Link to Publication

Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, Masters CL, Maruff P; AIBL Research Group. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. J Alzheimers Dis. 2017 Jan ;57(2):411-422.  Link to Publication

2016

Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, Scheltens P, Masters CL, Rowe CC. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. J Alzheimers Dis. 2016;49(4):1115-22.  Link to Publication

Kristensen TD, Raghava JM, Skjerbæk MW, Dhollander T, Syeda W, Ambrosen KS, Bojesen KB, Nielsen MØ, Pantelis C, Glenthøj BY, Ebdrup BH. Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2023 Dec;273(8):1797-1812.   Link to Publication

Barry N, Francis RJ, Ebert MA, Koh ES, Rowshanfarzad P, et.al. Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3970-3981.   Link to Publication

Abo-Shaban T, Lee CYQ, Hosie S, Balasuriya GK, Mohsenipour M, Johnston LA, Hill-Yardin EL.  GutMap: A New Interface for Analysing Regional Motility Patterns in ex vivo Mouse Gastrointestinal Preparations. Bio Protoc. 2023 Oct 5;13(19):e4831.   Link to Publication

Ravanfar P, Rushmore RJ, Lyall AE, Cropley V, Makris N, Desmond P, Velakoulis D, Shenton ME, Bush AI, Rossell SL, Pantelis C, Syeda WT, Phillipou A. Investigation of brain iron in anorexia nervosa, a quantitative susceptibility mapping study. J Eat Disord. 2023 Aug 21;11(1):142.   Link to Publication

Liu H, Durongbhan P, Davey CE, Stok KS. Image Registration in Longitudinal Bone Assessment Using Computed Tomography. Curr Osteoporos Rep. 2023 Aug;21(4):372-385.   Link to Publication

Koh ES, Gan HK, Senko C, Francis RJ, Ebert M, Lee ST, et.al. [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. BMJ Open. 2023 Aug 4;13(8):e071327.   Link to Publication

Durongbhan P, Silva MO, Li Z, Ansari N, Kour RYN, Davey CE, Stok KS. A microCT imaging protocol for reproducible and efficient quantitative morphometric analysis (QMA) of joint structures of the in situ mouse tibio-femoral joint. Bone. 2023 Jan;166:116606.   Link to Publication